(Q39761374)

14 September 2017

1 reference

title

Genetic variation in the human hepatic cytochrome P-450 system (English)

1 reference

14 September 2017

1 reference

W Kalow

1

1 reference

14 September 2017

publication date

1 January 1987

1 reference

European Journal of Clinical Pharmacology

14 September 2017

published in

1 reference

14 September 2017

volume

31

1 reference

14 September 2017

issue

6

1 reference

14 September 2017

page(s)

633-641

1 reference

The influence of enzyme induction on polymorphic sparteine oxidation

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF00541288

Genetic polymorphism of mephenytoin p(4')-hydroxylation: difference between Orientals and Caucasians

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00541288

Phenacetin O-deethylase: an activity of a cytochrome P-450 showing genetic linkage with that catalysing the 4-hydroxylation of debrisoquine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00541288

Genetic aspects of the polymodally distributed sulphoxidation of S-carboxymethyl-L-cysteine in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00541288

Interethnic differences in genetic polymorphism of debrisoquin and mephenytoin hydroxylation between Japanese and Caucasian populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00541288

Plasma concentrations of nortriptyline and its 10-hydroxy metabolite in depressed patients--relationship to the debrisoquine hydroxylation metabolic ratio

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00541288

Two RFLPs associated with the human P1450 gene linked to the MPI locus on chromosome 15 [HGM8 D15S8].

21 January 2018

1 reference

12 December 2020

The genetic polymorphism of sparteine metabolism

1 reference

12 December 2020

[Phenytoin poisoning in a degradation disorder, report of a case with cerebellar atrophy]

1 reference

12 December 2020

The molecular mechanisms of two common polymorphisms of drug oxidation--evidence for functional changes in cytochrome P-450 isozymes catalysing bufuralol and mephenytoin oxidation

1 reference

12 December 2020

The genetic defect of mephenytoin hydroxylation

1 reference

12 December 2020

Impairment of phenytoin parahydroxylation as a cause of severe intoxication

1 reference

12 December 2020

Oral hypoglycaemic agents. An update

1 reference

12 December 2020

Expression and chromosomal localization of the cytochrome P1-450 gene in human mitogen-stimulated lymphocytes

1 reference

12 December 2020

Genetics of drug transformation

1 reference

12 December 2020

Sparteine oxidation polymorphism in Denmark.

1 reference

12 December 2020

Localization of cytochrome P1-450 and P3-450 genes to mouse chromosome 9

1 reference

12 December 2020

Population distribution of placental benzo(α)pyrene metabolism in smokers

1 reference

12 December 2020

Tolbutamide kinetics in a normal Indian population

1 reference

12 December 2020

Polymorphisms of antipyrine and theophylline metabolism in man: molecular and clinical implications

1 reference

12 December 2020

The CO2 breath tests as monitors of the cytochrome P450 dependent mixed function monooxygenase system

1 reference

12 December 2020

A cytochrome P-450 gene family mapped to human chromosome 19

1 reference

12 December 2020

Aryl hydrocarbon hydroxylase inducibility and bronchogenic carcinoma.

1 reference

12 December 2020

Ecogenetics of Parkinson's disease: 4-hydroxylation of debrisoquine

1 reference

12 December 2020

Substrate specificity of the monooxygenase activity of hemoglobin

1 reference

12 December 2020

TheAhLocus: Genetic Regulation of the Metabolism of Carcinogens, Drugs, and Other Environmental Chemicals by Cytochrome P-450-Mediated Monooxygenase

1 reference

12 December 2020

Sparteine sulfate: A potent, capricious oxytocic

1 reference

12 December 2020

Inhibitory effects of neuroleptics on debrisoquine oxidation in man

1 reference

12 December 2020

Variations in aryl hydrocarbon hydroxylase activities in mitogen-activated human and nonhuman primate lymphocytes

1 reference

12 December 2020

Pharmacogenetics of tolbutamide metabolism in humans

1 reference

12 December 2020

A human cytochrome P-450 characterized by inhibition studies as the sparteine-debrisoquine monooxygenase

1 reference

12 December 2020

[Regulation mechanisms of the endoplasmic cytochrome P-450 systems of the liver]

1 reference

12 December 2020

Stereoselective pharmacokinetics of perhexiline

1 reference

12 December 2020

The problem of chemically reactive metabolites

1 reference

12 December 2020

Human-liver cytochromes P-450 involved in polymorphisms of drug oxidation

1 reference

12 December 2020

Oxidative metabolism of encainide: polymorphism, pharmacokinetics and clinical considerations

1 reference

12 December 2020

Debrisoquine polymorphism and the metabolism and action of metoprolol, timolol, propranolol and atenolol

1 reference

12 December 2020

Genetic variation of aryl hydrocarbon hydroxylase in human lymphocytes.

1 reference

12 December 2020

The regulation of cytochrome P-450 gene expression

1 reference

12 December 2020

Aryl hydrocarbon hydroxylase induction by benzo[a]anthracene: regulatory gene localized to the distal portion of mouse chromosome 17.

1 reference

12 December 2020

Assignment of the human 2,3,7,8-tetrachlorodibenzo-p-dioxin-inducible cytochrome P1-450 gene to chromosome 15

1 reference

12 December 2020

The immunological detection of a 21-OH deficiency mutation HLA supratype

1 reference

12 December 2020

Is the activation of aflatoxin B1 catalysed by the same form of cytochrome P-450 as that 4-hydroxylating debrisoquine in rat and/or man?

1 reference

12 December 2020

Pharmacogenetics of dextromethorphan O-demethylation in man.

1 reference

12 December 2020

Characterization of rat and human liver microsomal cytochrome P-450 forms involved in nifedipine oxidation, a prototype for genetic polymorphism in oxidative drug metabolism

1 reference

12 December 2020

Human dioxin-inducible cytochrome P1-450: complementary DNA and amino acid sequence

1 reference

12 December 2020

Variability in nifedipine pharmacokinetics and dynamics: a new oxidation polymorphism in man

1 reference

12 December 2020

Genes for cytochrome P-450 and their regulation.

1 reference

12 December 2020

Comparison of the flanking regions and introns of the mouse 2,3,7,8-tetrachlorodibenzo-p-dioxin-inducible cytochrome P1-450 and P3-450 genes

1 reference

12 December 2020

Localization of the human aryl hydrocarbon hydroxylase gene to the 2q31----2pter region of chromosome 2

1 reference

12 December 2020

Induction of drug-metabolizing enzymes: mechanisms and consequences

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00541288

1 reference

14 September 2017

1 reference